Nayden Denis 4
4 · Accretive Health, Inc. · Filed Oct 3, 2012
Insider Transaction Report
Form 4
Nayden Denis
Director
Transactions
- Award
Director Stock Option (right to buy)
2012-10-01$5.55/sh+2,704$15,007→ 2,704 totalExercise: $11.49From: 2012-10-01Exp: 2022-10-01→ Common Stock (2,704 underlying)
Holdings
- 428,630(indirect: By Trust)
Common Stock
- 635,568
Common Stock
Footnotes (2)
- [F1]Includes 77,000 shares previously held by the reporting person indirectly through the reporting person's grantor retained annuity trust ("GRAT"), which were distributed to the reporting person on September 13, 2012 and are now owned directly. The reporting person is sole trustee and sole annuitant of the GRAT, which was established for estate planning purposes.
- [F2]This option was issued to the reporting person pursuant to the Accretive Health director compensation plan in lieu of retainer fees of $15,000.